Stop CMV Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Stop CMV Act of 2025, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Technology, Government Operations.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H66CB52D6F71745B0B617FEB9B9A2B658: 1. Short title This Act may be cited as Stop CMV Act of 2025.
- Section H809EAC08F517453997D3D77CD20B6FCF: 2. Screening of congenital Cytomegalovirus Part A of title XI of the Public Health Service Act is amended by inserting after section 1116 (42 U.S.C. 300b–15)...
- Section HBC2297A97C6247DEA1301EDB589F9F3E: 1116A. Screening of congenital Cytomegalovirus Each hospital or other health care entity caring for infants who are 21 days or less of age (as designated by...
- Section H0F1FF8B89F48465C9CC5087D837E0410: 3. Advisory committee on heritable disorders in newborns and children Section 1111(b) of the Public Health Service Act (42 U.S.C. 300b–10(b)) is amended— in...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Stop CMV Act of 2025, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Technology, Government Operations
Primary Purpose
This bill, Stop CMV Act of 2025, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeMr. Blumenthal (for himself, Mr. Marshall, and Mr. Kelly) introduced …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
- "the_administrator"
- → The Administrator identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology